| Literature DB >> 24244821 |
Bora Kim1, Jee-Young Lee, Ha-Yeon Lee, Ky-Youb Nam, Jongil Park, Su Min Lee, Jin Eun Kim, Joo Dong Lee, Jae Sung Hwang.
Abstract
We investigated the inhibitory effects of hesperidin on melanogenesis. To find melanosome transport inhibitor from natural products, we collected the structural information of natural products from Korea Food and Drug Administration (KFDA) and performed pharmacophore-based in silico screening for Rab27A and melanophilin (MLPH). Hesperidin did not inhibit melanin production in B16F10 murine melanoma cells stimulated with α-melanocyte stimulating hormone (α-MSH), and also did not affect the catalytic activity of tyrosinase. But, hesperidin inhibited melanosome transport in melanocyte and showed skin lightening effect in pigmented reconstructed epidermis model. Therefore, we suggest that hesperidin is a useful inhibitor of melanosome transport and it might be applied to whitening agent.Entities:
Keywords: Hesperidin; Melanophilin; Melanosome transport; Pigmented reconstructed epidermis model; Rab27A
Year: 2013 PMID: 24244821 PMCID: PMC3825197 DOI: 10.4062/biomolther.2013.032
Source DB: PubMed Journal: Biomol Ther (Seoul) ISSN: 1976-9148 Impact factor: 4.634
The docking score for 10 hits
| Compound name | Dock Score |
|---|---|
|
| |
| Acetoside | 6.45 |
| Cimicifugoside H-1 | 6.11 |
| Albiflorin | 6.02 |
| 23-O-acetylshengmanol 3-xyloside | 5.90 |
| 3,5-Di-O-caffeoylquinic acid | 5.77 |
| Hesperidin | 5.72 |
| Forsythiaside | 5.56 |
| Neohesperidin dihydro-chalcone | 5.54 |
| Loniceroside A | 5.32 |
| Saikosaponin C | 5.20 |
Fig. 1.The structure of hit compounds. (A) Structure of 10 hits (B) Structure of hesperidin.
Fig. 2.Results of Docking study. (A) Overall structure of hesperidin and MLPH (B) Interaction model between hesperidin and MLPH. Yellow residues participated hydrogen bonding interactions with hesperidin. Black dashed lines are depicted hydrogen bonds (C) Surface model of hesperidin and MLPH.
Fig. 3.Measurement of the inhibitory effect on mushroom tyrosinase and inhibitory effect on melanogenesis in B16F10 melanoma cells (A) The tyrosinase activity assay was performed with mushroom tyrosinase. (B) Cells were treated with various concentrations (5-20 μM) of Hesperidin for a total of 7 days. Melanin content of cells was determined. The data shown represent the mean ± SD derived from three determinations. Kojic acid and resveratrol were used as a positive control. **p<0.01 indicated statistically significant differences from the α-MSH treated group.
Fig. 4.Aggregation of melanosome (A) and quantification of the number of aggregated cells (B) treated with DMSO or 10 μM hesperidin for 72 hours. The number of aggregated cells was counted as described material and method.
Fig. 5.Macroscopic views of Pigmented reconstructed epidermis model treated with hesperidin. Different concentrations of hesperidin, and the vehicle (0.1% DMSO) were applied topically on the reconstructed skin and tissues were monitored for up to 14 days. *p<0.05 indicated statistically significant differences from the vehicle. L values are data for skin lightness using semi-quantitative image analysis program.